As of 2026-04-05, the Relative Valuation of Xphyto Therapeutics Corp (XPHY.CN) is (1.34) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 CAD, the upside of Xphyto Therapeutics Corp based on Relative Valuation is -370.6%.
The range of the Relative Valuation is (1.07) - (1.50) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 12.2x | 10.9x |
| Forward P/E multiples | 8.7x - 12.4x | 10.9x |
| Fair Price | (1.07) - (1.50) | (1.34) |
| Upside | -316.5% - -403.4% | -370.6% |
| Date | P/E |